Sutro Biopharma, Inc. focuses on creating protein therapeutics for cancer and autoimmune disorders.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma.
